ACRO BIOMEDICAL CO., LTD. (ACBM) Operating cash flow 2017–2025
ACRO BIOMEDICAL CO., LTD. (ACBM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$196,302FY2025 · since FY2017: -$463,344 → -$196,302
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$196,302 | -435.0% |
| FY2024 | -$36,692 | -137.6% |
| FY2023 | -$15,446 | +89.5% |
| FY2022 | -$147,481 | -149.3% |
| FY2021 | $299,335 | +250.1% |
| FY2020 | -$199,460 | -234.1% |
| FY2019 | -$59,709 | +57.5% |
| FY2018 | -$140,419 | +69.7% |
| FY2017 | -$463,344 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACBM financial trends
ACBM RevenueACBM Net incomeACBM Net marginACBM Gross profitACBM Gross marginACBM Operating incomeACBM Operating marginACBM Free cash flowACBM Capital expendituresACBM Return on equityACBM Stock buybacksACBM Dividends paidACBM Total assetsACBM Total liabilitiesACBM Shareholders’ equityACBM overview →